基于腺的超分子皮肤输送系统用于头发调节和恢复
Yixuan Tang1, Weihao Gao1, Hongwei Fu2
1College of Frontier Sciences, School of Materials Science and Engineering, Harbin Institute of Technology, Shenzhen 518055, China. zhangjiaheng@hit.edu.cn.
Journal of materials chemistry. B
|February 26, 2026
概括
一种新的腺素 (Ado) 共晶,TA-Ado,克服了溶解性差和皮肤透问题. 这种增强的腺素输送改善了用于化品应用的抗氧化,抗炎和头发生长特性.
科学领域:
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
- 皮肤病学 皮肤病学
背景情况:
- 氨酸 (Ado) 具有重要的生物活性,包括抗炎,抗氧化和组织修复功能.
- 腺素的不良物理化学特性,如低水溶性和透皮透性,限制了其生物可用性和有效性.
- 开发先进的输送系统对于增强阿诺辛的治疗和化品潜力至关重要.
研究的目的:
- 设计一种新的氨酸 (TA-Ado) 超分子共晶体,以改善其物理化学和生物特性.
- 评估TA-Ado共晶体的透皮透,生物相容性和协同生物活性.
- 评估TA-Ado在皮肤和化品应用中的潜力,特别是在头皮健康和头发生长方面.
主要方法:
- 通过键驱动的自我组装形成超分子共晶体.
- 使用分子建模,量子计算和光谱分析进行结构性表征.
- 在体外通过皮肤透测定,生物相容性测试和生物活性评估 (抗氧化剂,抗炎药物,抗菌剂,脂质调节).
- 抑制5α-还原酶活性,活体毛囊生长促进和皮质完整性评估.
- 对头皮条件的安全性,稳定性和疗效的临床评估.
主要成果:
- TA-Ado共晶体表现出结构稳定性和结晶独立性.
- TA-Ado显著增强了Adenosine通过皮肤透的2.66倍,具有出色的生物相容性.
- 与自由腺素相比,TA-Ado表现出优越的协同抗氧化,抗炎,抗微生物和脂质调节作用.
- 观察到显著抑制5α-还原酶活性 (81.93%),促进体外毛囊生长,改善皮质完整性.
- 临床研究证实TA-Ado在减少头皮炎症,脂质分泌和脱发方面的安全性和有效性.
结论:
- TA-Ado 共同晶体作为腺的有效输送平台,增强其物理化学和生物性能.
- TA-Ado显示出皮肤和化品应用的巨大潜力,特别是在头皮健康和抗脱发治疗方面.
- 这种超分子方法为开发化学中先进的功能性材料提供了一个有前途的战略.
更多相关视频
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
2.3K
09:42Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
7.9K
相关概念视频
01:18Transdermal Drug Delivery Systems
57
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
57
01:23Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97
01:24Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
53
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
53
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59
01:20Accessory Structures of the Skin: Hair Growth and Types
2.7K
Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...
2.7K